AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia

Is this Study for You?

Let's Get Started!

Details
Age

Child

Eligibility

Children and Adolescents who have completed a prior TransCon CNP trial.

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Klane White

Klane White

Study ID

Protocol Number: 23-0807

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers